BIT
STML

BlackRock Institutional Trust’s Stemline Therapeutics, Inc. STML Stock Holding History

BlackRock Institutional Trust’s Portfolio STML Stock Details STML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$2.96M Buy
276,656
+37,424
+16% +$453K ﹤0.01% 2916
2016
Q3 		$2.59M Buy
239,232
+51,804
+28% +$421K ﹤0.01% 2953
2016
Q2 		$1.27M Buy
187,428
+11,292
+6% +$71.3K ﹤0.01% 3224
2016
Q1 		$821K Sell
176,136
-17,520
-9% -$85.6K ﹤0.01% 3337
2015
Q4 		$1.22M Buy
193,656
+17,360
+10% +$141K ﹤0.01% 3275
2015
Q3 		$1.56M Buy
176,296
+47,344
+37% +$497K ﹤0.01% 3201
2015
Q2 		$1.52M Sell
128,952
-11,055
-8% -$153K ﹤0.01% 3223
2015
Q1 		$2.03M Buy
140,007
+36,376
+35% +$557K ﹤0.01% 3108
2014
Q4 		$1.77M Sell
103,631
-3,111
-3% -$44.9K ﹤0.01% 3160
2014
Q3 		$1.33M Sell
106,742
-18,604
-15% -$229K ﹤0.01% 3229
2014
Q2 		$1.84M Buy
125,346
+9,523
+8% +$146K ﹤0.01% 3226
2014
Q1 		$2.36M Buy
115,823
+2,000
+2% +$48.5K ﹤0.01% 3097
2013
Q4 		$2.23M Buy
113,823
+3,885
+4% +$104K ﹤0.01% 3116
2013
Q3 		$4.98M Buy
109,938
+10,639
+11% +$347K ﹤0.01% 2733
2013
Q2 		$2.37M Buy
+99,299
New +$1.58M ﹤0.01% 3003

Other funds holding STML

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock Institutional Trust's STML Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Stemline Therapeutics, Inc. (STML) stake by 16% in Q4 2016, buying an estimated $453K and bringing the position to 276,656 shares worth $2.96M. The position accounts for ﹤0.01% of the portfolio, ranked #2916.

BlackRock Institutional Trust first reported a position in STML in Q2 2013 and has held it in 15 quarters since. The position peaked at $4.98M in Q3 2013. 74 funds tracked by Wall St. Rank hold STML as of Q4 2016.

  • BlackRock Institutional Trust held 276,656 shares of Stemline Therapeutics, Inc. worth $2.96M as of Q4 2016.
  • BlackRock Institutional Trust bought 37,424 Stemline Therapeutics, Inc. shares in Q4 2016, an estimated $453K.
  • Stemline Therapeutics, Inc. made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2916 holding.
  • BlackRock Institutional Trust first reported a position in Stemline Therapeutics, Inc. in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Institutional Trust's Stemline Therapeutics, Inc. position peaked at $4.98M in Q3 2013.
  • 74 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.